Managing Amyloidosis in 2024: Diagnosis and Treatment

Indy Hematology Review

M. Gertz

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

Managing Infectious Complications With Bispecific and CAR-T Therapy …

SOHO Brazil 2024

N. S. Raje

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Rush University Medical Center

A. Suvannasankha

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

Management of AL Amyloidosis

GRACE

S. Rajeeve

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

Experts Discuss the Diagnosis and Management of High-Risk Multiple M…

MyCancerHaven

R. Vij, M. Alsina

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

High-Risk Myeloma: Updates in Defining and Managing

Rush University Medical Center

J. Zonder

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

AL Amyloidosis Treatment Updates

Yale Cancer Center

T. Parker

Multiple Myeloma: Initial Treatment Approaches

University of Colorado Division of Hematology

A. Hirose

Experts Discuss Novel Antibodies for the Management of Amyloidosis

MyCancerHaven

R. Vij, S. Lentzsch

Renal AL Amyloid

Yale Cancer Center

R. Luciano

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free Light…

Insights from 2023 ASH Annual Meeting

T. Einarsson Long

Interpreting a PYP Study for TTR Cardiac Amyloid

American Society of Nuclear Cardiology

P. Soman, M. Harinstein, S. Divakaran